Amyloid

The Journal of Protein Folding Disorders

Volume 29, 2022 - Issue 2

204

Views

CrossRef citations to date

Altmetric

Letters to the Editor

AA amyloidosis in inflammatory active malignant paraganglioma

Sandra Ihnea Interdisciplinary Amyloidosis Center of Northern Bavaria, Würzburg, Germany;b University and University Hospital Würzburg, Würzburg, GermanyCorrespondence[email protected]

Malte Kircherc Nuclear Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany

Aikaterini Papagiannia Interdisciplinary Amyloidosis Center of Northern Bavaria, Würzburg, Germany;b University and University Hospital Würzburg, Würzburg, Germany

Oliver Goetzea Interdisciplinary Amyloidosis Center of Northern Bavaria, Würzburg, Germany;b University and University Hospital Würzburg, Würzburg, Germany

Caroline Morbacha Interdisciplinary Amyloidosis Center of Northern Bavaria, Würzburg, Germany;b University and University Hospital Würzburg, Würzburg, Germany

Rudolf A. Wernerb University and University Hospital Würzburg, Würzburg, Germany

Daniel Zellera Interdisciplinary Amyloidosis Center of Northern Bavaria, Würzburg, Germany;b University and University Hospital Würzburg, Würzburg, Germany

Claudia Sommera Interdisciplinary Amyloidosis Center of Northern Bavaria, Würzburg, Germany;b University and University Hospital Würzburg, Würzburg, Germany

Andreas Rosenwaldb University and University Hospital Würzburg, Würzburg, Germany

Kerstin Amannd Department of Nephropathology, University Erlangen, Erlangen, Germany

Reinhold P. Linkee Reference Center of Amyloid Diseases, Munich, Germany

Constantin Lapac Nuclear Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany

Hermann Einselea Interdisciplinary Amyloidosis Center of Northern Bavaria, Würzburg, Germany;b University and University Hospital Würzburg, Würzburg, Germany

Andreas Geiera Interdisciplinary Amyloidosis Center of Northern Bavaria, Würzburg, Germany;b University and University Hospital Würzburg, Würzburg, Germany

Laura Obicif Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Giovanni Palladinif Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Stefan Knopa Interdisciplinary Amyloidosis Center of Northern Bavaria, Würzburg, Germany;b University and University Hospital Würzburg, Würzburg, Germany

Stefan Störka Interdisciplinary Amyloidosis Center of Northern Bavaria, Würzburg, Germany;b University and University Hospital Würzburg, Würzburg, Germany

show all

References

Obici L, Merlini G. AA amyloidosis: basic knowledge, unmet needs and future treatments. Swiss Med Wkly. 2012;142:w13580.
PubMed Web of Science ®Google Scholar
Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis, tours, France, 18-22 april 2004. Am J Hematol. 2005;79(4):319–328.
PubMed Web of Science ®Google Scholar
Law WP, Wang W, Moore P, et al. Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study. Amyloid. 2017;24(Supp 1):162.
PubMedGoogle Scholar
Ihne S, Morbach C, Obici L, et al. Amyloidosis in heart failure. Curr Heart Fail Rep. 2019;16(6):285–303.
PubMedGoogle Scholar
Goetze O, Selzner N, Fruehauf H, et al. 13C-methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry. Aliment Pharmacol Ther. 2007;26(2):305–311.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

AA amyloidosis in inflammatory active malignant paraganglioma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

AA amyloidosis in inflammatory active malignant paraganglioma

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date